AFP and Cirrhosis: However, many studies have shown that several independent risk factors, including age (23), race (5, 9), alpha-fetoprotein (AFP) status (23), cirrhosis (4), and treatment strategies (1, 5, 9, 24–26), affect the survival and prognosis of patients with CHC.